Haibo Liu

Haibo Liu has a diverse work experience in the pharmaceutical and biotech industry. Haibo currently holds the role of Director of Medicinal Chemistry at Matchpoint Therapeutics, starting in March 2022. Prior to this, they worked at Bristol Myers Squibb as a Senior Principal Scientist from January 2021 to March 2022 and as a Principal Scientist from June 2020 to January 2021. Haibo also worked at Celgene as a Sr. Scientist from March 2012 to January 2021. Before that, they were a Scientist at Avila Therapeutics from February 2011 to March 2012. Haibo started their career as a Research Chemist at Broad Institute from February 2007 to February 2011. Haibo began their professional journey as a Research Fellow at MSKCC in 2004.

Haibo Liu completed their Bachelor of Science (BS) degree at Peking University. Following this, they pursued their PhD in chemistry at Stanford University from 1999 to 2004.